The Role of Citicoline and Coenzyme Q10 in Retinal Pathology

Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration are common retinal diseases responsible for most of the blindness causes in the working-age and elderly populations in developed countries. Many of the current treatments used in these pathologies fail to stop or slow the progression of the disease. Therefore, other types of treatments with neuroprotective characteristics may be necessary to allow a more satisfactory management of the disease. Citicoline and coenzyme Q10 are molecules that have neuroprotective, antioxidant, and anti-inflammatory properties, and their use could have a beneficial effect in ocular neurodegenerative pathologies. This review provides a compilation, mainly from the last 10 years, of the main studies that have been published on the use of these drugs in these neurodegenerative diseases of the retina, analyzing the usefulness of these drugs in these pathologies.

[1]  R. Wubbels,et al.  Clinical outcomes of treatment with idebenone in Leber's hereditary optic neuropathy in the Netherlands: A national cohort study , 2022, Acta ophthalmologica.

[2]  M. Pinazo-Durán,et al.  Understanding Neurodegeneration from a Clinical and Therapeutic Perspective in Early Diabetic Retinopathy , 2022, Nutrients.

[3]  J. Salazar,et al.  Retinal microglial activation in glaucoma: evolution over time in a unilateral ocular hypertension model , 2021, Neural regeneration research.

[4]  F. Pallardó,et al.  Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction , 2021, Cellular and Molecular Life Sciences.

[5]  K. Kasarełło,et al.  Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma , 2021, Antioxidants.

[6]  S. Capaccioli,et al.  Effect of space flight on the behavior of human retinal pigment epithelial ARPE-19 cells and evaluation of coenzyme Q10 treatment , 2021, Cellular and Molecular Life Sciences.

[7]  María Hernández,et al.  Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Age Related Macular Degeneration, Role in Pathophysiology, and Possible New Therapeutic Strategies , 2021, Antioxidants.

[8]  M. Varano,et al.  Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 36-Month Pilot Study Evaluating Macular Electrophysiological Changes , 2021, Advances in Therapy.

[9]  T. Wong,et al.  Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. , 2021, Ophthalmology.

[10]  Kevin C. Chan,et al.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control , 2021, Neurotherapeutics.

[11]  M. Coletta,et al.  Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review , 2021, Pharmaceuticals.

[12]  J. Sahel,et al.  Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study , 2021, BioDrugs.

[13]  Wenxin Wang,et al.  Thermo-Responsive PLGA-PEG-PLGA Hydrogels as Novel Injectable Platforms for Neuroprotective Combined Therapies in the Treatment of Retinal Degenerative Diseases , 2021, Pharmaceutics.

[14]  N. Gueven,et al.  Novel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy , 2021, International journal of molecular sciences.

[15]  Timothy E. Yap,et al.  Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain , 2020, International journal of molecular sciences.

[16]  C. Costagliola,et al.  Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study , 2020, Molecules.

[17]  C. Nucci,et al.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma , 2020, Nutrients.

[18]  Keun-Young Kim,et al.  Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function , 2020, Antioxidants.

[19]  N. Newman,et al.  Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[20]  I. Hargreaves,et al.  Disorders of Human Coenzyme Q10 Metabolism: An Overview , 2020, International journal of molecular sciences.

[21]  S. Khanal,et al.  Prevalence, Pattern and Risk Factors of Retinal Diseases Among an Elderly Population in Nepal: The Bhaktapur Retina Study , 2020, Clinical ophthalmology.

[22]  L. Rossetti,et al.  Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial , 2020, Journal of glaucoma.

[23]  M. C. Kenney,et al.  Role of Citicoline in an in vitro AMD model , 2020, Aging.

[24]  M. Varano,et al.  Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 3-year Pilot Study Evaluating Morpho-Functional Retinal Changes , 2020, Advances in Therapy.

[25]  A. Caporossi,et al.  Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma , 2020, Nutrients.

[26]  A. Schauss,et al.  Citicoline (CDP-Choline) , 2020 .

[27]  Z. Aktaş,et al.  Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model , 2020, European journal of ophthalmology.

[28]  F. Aslan,et al.  Neuroprotective Effect of Citicoline Eye Drops on Corneal Sensitivity After LASIK. , 2019, Journal of refractive surgery.

[29]  R. Bekdash.  Neuroprotective Effects of Choline and Other Methyl Donors , 2019, Nutrients.

[30]  B. Newland,et al.  The ying and yang of idebenone: Not too little, not too much - cell death in NQO1 deficient cells and the mouse retina. , 2019, Free radical biology & medicine.

[31]  M. Lanza,et al.  Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up , 2019, Front. Pharmacol..

[32]  B. Pemp,et al.  Visual function in chronic Leber’s hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[33]  J. Quiles,et al.  The Paradox of Coenzyme Q10 in Aging , 2019, Nutrients.

[34]  G. Coppola,et al.  Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study , 2019, PloS one.

[35]  E. Rulli,et al.  Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol , 2019, Advances in Therapy.

[36]  R. Ciuluvică,et al.  The neuroprotective role of citicoline treatment in glaucoma – 6 months results of a prospective therapeutic trial , 2019, Romanian journal of ophthalmology.

[37]  G. Wollstein,et al.  Cholinergic nervous system and glaucoma: From basic science to clinical applications , 2019, Progress in Retinal and Eye Research.

[38]  I. Bravo-Osuna,et al.  Simultaneous co‐delivery of neuroprotective drugs from multi‐loaded PLGA microspheres for the treatment of glaucoma , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[39]  C. Nucci,et al.  Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma , 2019, Neural regeneration research.

[40]  P. Yılmazbaş,et al.  Evaluation of oxidative stress in pseudo-exfoliative glaucoma patients treated with and without topical coenzyme Q10 and vitamin E , 2018, European journal of ophthalmology.

[41]  J. Blusztajn,et al.  Choline: The Underconsumed and Underappreciated Essential Nutrient , 2018, Nutrition today.

[42]  R. Weinreb,et al.  Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration. , 2018, Biochemical and biophysical research communications.

[43]  R. Simó,et al.  Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration , 2018, International journal of molecular sciences.

[44]  P. Yu-Wai-Man,et al.  Leber Hereditary Optic Neuropathy—Light at the End of the Tunnel? , 2018, Asia-Pacific journal of ophthalmology.

[45]  N. Newman,et al.  International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy , 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[46]  X. Shu,et al.  Therapeutic Potential of Co-enzyme Q10 in Retinal Diseases. , 2017, Current medicinal chemistry.

[47]  G. Malaguarnera,et al.  Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension , 2017, Mitochondrion.

[48]  M. Valenti,et al.  The use of choline in association with the Bangerter filters for the treatment of amblyopia. , 2017, International journal of ophthalmology.

[49]  F. Garaci,et al.  New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system. , 2016, European journal of pharmacology.

[50]  M. Votruba,et al.  A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function , 2016, Neuroscience.

[51]  Jun-feng Mao,et al.  Citicoline retards myopia progression following form deprivation in guinea pigs , 2016, Experimental biology and medicine.

[52]  F. Pacheco-Moisés,et al.  The effect of ubiquinone and combined antioxidant therapy on oxidative stress markers in non-proliferative diabetic retinopathy: A phase IIa, randomized, double-blind, and placebo-controlled study , 2015, Redox report : communications in free radical research.

[53]  J. Secades.  Citicoline: pharmacological and clinical review, 2016 update. , 2016, Revista de neurologia.

[54]  Jin-Hyun Jeong,et al.  Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines , 2015, PloS one.

[55]  G. Van Stavern,et al.  Leber hereditary optic neuropathy: current perspectives , 2015, Clinical ophthalmology.

[56]  A. Kampik,et al.  Idebenone Prevents Oxidative Stress, Cell Death and Senescence of Retinal Pigment Epithelium Cells by Stabilizing BAX/Bcl-2 Ratio , 2015, Ophthalmologica.

[57]  V. Parisi,et al.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[58]  N. Gueven,et al.  Border between natural product and drug: Comparison of the related benzoquinones idebenone and coenzyme Q10 , 2015, Redox biology.

[59]  T. Wong,et al.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. , 2014, Ophthalmology.

[60]  V. Parisi,et al.  Effects of Coenzyme Q10 in Conjunction With Vitamin E on Retinal-evoked and Cortical-evoked Responses in Patients With Open-angle Glaucoma , 2014, Journal of glaucoma.

[61]  V. Parisi,et al.  A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy , 2014, Indian journal of ophthalmology.

[62]  Robert N Weinreb,et al.  Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. , 2014, Investigative ophthalmology & visual science.

[63]  M. Patil,et al.  Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: A randomized controlled trial , 2014, Indian journal of ophthalmology.

[64]  R. Klein,et al.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[65]  M. Cordero,et al.  Clinical applications of coenzyme Q10. , 2014, Frontiers in bioscience.

[66]  Mark Ellisman,et al.  Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury , 2013, Apoptosis.

[67]  Mark Ellisman,et al.  Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes , 2013, Cell Death and Disease.

[68]  A. Kampik,et al.  Idebenone Prevents Human Optic Nerve Head Astrocytes From Oxidative Stress, Apoptosis, and Senescence by Stabilizing BAX/Bcl-2 Ratio , 2013, Journal of glaucoma.

[69]  L. Rossetti,et al.  Citicoline Oral Solution in Glaucoma: Is There a Role in Slowing Disease Progression? , 2013, Ophthalmologica.

[70]  E. Pretorius,et al.  Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. , 2013, Nutrition reviews.

[71]  L. Papucci,et al.  Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage. , 2012, Investigative ophthalmology & visual science.

[72]  N. Gueven,et al.  Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber’s Hereditary Optic Neuropathy , 2012, PloS one.

[73]  L. Papucci,et al.  Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo , 2012, Journal of radiation research.

[74]  V. Giorgio,et al.  The effects of idebenone on mitochondrial bioenergetics , 2012, Biochimica et biophysica acta.

[75]  E. Biasi.  The effects of dietary choline , 2011, Neuroscience Bulletin.

[76]  P. Chinnery,et al.  A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy , 2011, Brain : a journal of neurology.

[77]  S. Somfai-Relle,et al.  Single- and Repeated-Dose Oral Toxicity Studies of Citicoline Free-Base (Choline Cytidine 5′-Pyrophosphate) in Sprague-Dawley Rats , 2009, International journal of toxicology.

[78]  S. Hayreh,et al.  Ischemic Optic Neuropathy , 2004, Albert and Jakobiec's Principles and Practice of Ophthalmology.

[79]  J. Evans,et al.  Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis , 2008, Eye.

[80]  S. Zeisel,et al.  Choline: Dietary Requirements and Role in Brain Development. , 2007, Nutrition today.

[81]  J. Féher,et al.  Improvement of Visual Functions and Fundus Alterations in Early Age-Related Macular Degeneration Treated with a Combination of Acetyl-L-Carnitine, n-3 Fatty Acids, and Coenzyme Q10 , 2005, Ophthalmologica.

[82]  G. Mannino,et al.  Mitotropic Compounds for the Treatment of Age-Related Macular Degeneration , 2003, Ophthalmologica.

[83]  D. Yorston,et al.  Retinal Diseases and VISION 2020. , 2003, Community eye health.

[84]  Sergio Capaccioli,et al.  Concomitant effect of topical ubiquinone Q10 and vitamin E to prevent keratocyte apoptosis after excimer laser photoablation in rabbits. , 2002, Journal of refractive surgery.

[85]  G. Carella,et al.  Does Coenzyme Q10 Play a Role in Opposing Oxidative Stress in Patients with Age-Related Macular Degeneration? , 2000, Ophthalmologica.

[86]  S. Siano,et al.  Prevention of Corneal Keratocyte Apoptosis after Argon Fluoride Excimer Laser Irradiation with the Free Radical Scavenger Ubiquinone Q10 , 2000, European journal of ophthalmology.

[87]  L. D. Del Priore,et al.  Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. , 1999, Survey of ophthalmology.

[88]  its Panel on Folate,et al.  STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .

[89]  P. Zaniol,et al.  The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzyme Q10 treatment in retinitis pigmentosa. , 1994, Molecular aspects of medicine.